KIF21A anticorps (AA 948-963)
-
- Antigène Voir toutes KIF21A Anticorps
- KIF21A (Kinesin Family Member 21A (KIF21A))
-
Épitope
- AA 948-963
-
Reactivité
- Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp KIF21A est non-conjugé
-
Application
- Western Blotting (WB)
- Séquence
- CKRREKLSKR REKIVKE
- Réactivité croisée
- Humain, Souris, Rat (Rattus)
- Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo Rt
- Attributs du produit
- KIF21A (Kinesin Family Member 21A)
- Purification
- Purified by Protein A affinity chromatography.
- Immunogène
- Synthetic peptide corresponding to amino acids 948-963 (CKRREKLSKRREKIVKE) of mouse KIF21A with an N-terminal cysteine added for conjugation purposes (KLH coupled).
- Isotype
- IgG
- Top Product
- Discover our top product KIF21A Anticorps primaire
-
-
- Indications d'application
- Optimal working conditions should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Supplied as a liquid in 0.1M Tris-glycine, pH 7.4, 0.15M sodium chloride, 0.05 % sodium azide before the addition of glycerol to 30 %.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- 4°C (-20°C Glycerol)
-
- Antigène
- KIF21A (Kinesin Family Member 21A (KIF21A))
- Autre désignation
- KIF21A (KIF21A Produits)
- Synonymes
- anticorps CG5300, anticorps DmCG5300, anticorps DmKlp31D, anticorps DmKlp31E, anticorps Dmel\\CG5300, anticorps KIF21A, anticorps kif21a, anticorps DKFZp469O1020, anticorps CFEOM1, anticorps FEOM1, anticorps FEOM3A, anticorps AI850764, anticorps mKIAA1708, anticorps kinesin family member 21A, anticorps Kinesin-like protein at 31E, anticorps kinesin family member 21A L homeolog, anticorps kinesin family member 21B, anticorps Kinesin family member 21A, putative, anticorps KIF21A, anticorps Klp31E, anticorps kif21a.L, anticorps kif21b, anticorps CNA02460, anticorps AaeL_AAEL001662, anticorps CpipJ_CPIJ000963, anticorps CpipJ_CPIJ014480, anticorps CGB_B3030W, anticorps kif21a, anticorps Kif21a
- Pathways
- M Phase
-